1. Home
  2. SHAK vs KNSA Comparison

SHAK vs KNSA Comparison

Compare SHAK & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shake Shack Inc.

SHAK

Shake Shack Inc.

HOLD

Current Price

$98.77

Market Cap

3.5B

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$54.60

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHAK
KNSA
Founded
2004
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.5B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
SHAK
KNSA
Price
$98.77
$54.60
Analyst Decision
Buy
Strong Buy
Analyst Count
26
7
Target Price
$117.29
$60.86
AVG Volume (30 Days)
924.0K
795.8K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
354.17
225.00
EPS
1.09
0.27
Revenue
$1,445,306,000.00
$677,564,000.00
Revenue This Year
$16.58
$37.48
Revenue Next Year
$15.07
$17.87
P/E Ratio
$94.08
$198.13
Revenue Growth
15.38
60.09
52 Week Low
$76.51
$25.71
52 Week High
$142.23
$54.31

Technical Indicators

Market Signals
Indicator
SHAK
KNSA
Relative Strength Index (RSI) 51.67 71.26
Support Level $98.42 $40.67
Resistance Level $106.19 N/A
Average True Range (ATR) 3.97 2.27
MACD -0.32 1.15
Stochastic Oscillator 19.82 96.82

Price Performance

Historical Comparison
SHAK
KNSA

About SHAK Shake Shack Inc.

Shake Shack Inc is a roadside burger stand. It serves a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine, and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order, and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh-brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water. Geographically, the company generates the majority of its revenue from the United States.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: